Biocept Inc. (BIOC): Volume reached to 9.37 million


Biocept Inc. (NASDAQ:BIOC) changes shares on Thursday trading session, with a change of -1.11% or -$0.01 shares. The trading starts at $0.725 and closed at $0.70 throughout the day. The trading session low price was $0.685 and day high was $0.725 on Thursday, June 25. After the session, the Healthcare sector daily volume shifted to 9.37 million while its average volume is 26.57M. In other hand, the BIOC market cap reached to $99.40M. While, its current target price is $0.69 according to WSJ.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -26.97% and up 55.88% for month. Its quarterly performance was 126.51% above, while its half year performance is up 191.39%. BIOC yearly performance stood at negative -38.05% and rise 142.59% for year-to-date. Current recommendation for Biocept Inc. is 2.00.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. BIOC EPS (TTM) for 12-month is -0.93. EPS for this year is 86.40%, while for the next year its value is -0.20. Its EPS Q/Q reached 82.80%. It has an EPS of 67.90% up for past five years and for the next five years will be up 40.00%.

The company posted an EPS (TTM) of -0.93. Comparing with last year, the average estimated EPS was -1.43 which is lower than -0.2 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for BIOC rise 41.29% for period of 200 days. SMA for 50 days was 42.79% which is showing green signal, while SMA-20 was 17.27%. The moving average value for Biocept Inc. (BIOC) is 0.3870 and 0.5306 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in BIOC stock. On Jun 12, HALE DAVID F, Director, sold 604 trading shares at the cost of $0.56, which valued at 335.0. On Jun 12, HALE DAVID F, Director, sold 556 shares at the cost of $0.56, with total shares of 867.